149 related articles for article (PubMed ID: 11918534)
21. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses.
Barner M; Mohrs M; Brombacher F; Kopf M
Curr Biol; 1998 May; 8(11):669-72. PubMed ID: 9635196
[TBL] [Abstract][Full Text] [Related]
22. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells.
Bengtsson A; Lundberg M; Avila-Cariño J; Jacobsson G; Holmgren A; Scheynius A
Clin Exp Immunol; 2001 Mar; 123(3):350-60. PubMed ID: 11298119
[TBL] [Abstract][Full Text] [Related]
23. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
[TBL] [Abstract][Full Text] [Related]
24. Crosslinking of CD30 on activated human Th clones enhances their cytokine production and downregulates the CD30 expression.
Bengtsson A; Scheynius A; Avila-Cariño J
Scand J Immunol; 2000 Dec; 52(6):595-601. PubMed ID: 11119266
[TBL] [Abstract][Full Text] [Related]
25. CD30 ligand in lymphoma patients with CD30+ tumors.
Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
[TBL] [Abstract][Full Text] [Related]
26. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
[TBL] [Abstract][Full Text] [Related]
27. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
[TBL] [Abstract][Full Text] [Related]
28. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
[TBL] [Abstract][Full Text] [Related]
29. Opposite role for interleukin-4 and interferon-gamma on CD30 and lymphocyte activation gene-3 (LAG-3) expression by activated naive T cells.
Annunziato F; Manetti R; Cosmi L; Galli G; Heusser CH; Romagnani S; Maggi E
Eur J Immunol; 1997 Sep; 27(9):2239-44. PubMed ID: 9341765
[TBL] [Abstract][Full Text] [Related]
30. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
31. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M
Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
[TBL] [Abstract][Full Text] [Related]
34. IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms.
Wurtz O; Bajénoff M; Guerder S
Int Immunol; 2004 Mar; 16(3):501-8. PubMed ID: 14978023
[TBL] [Abstract][Full Text] [Related]
35. Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: failure to down-regulate IL-12 receptor beta 2-chain expression.
Yin Z; Zhang DH; Welte T; Bahtiyar G; Jung S; Liu L; Fu XY; Ray A; Craft J
J Immunol; 2000 Mar; 164(6):3056-64. PubMed ID: 10706694
[TBL] [Abstract][Full Text] [Related]
36. Increased accumulation of CD30 ligand-positive mast cells associates with eosinophilic inflammation in nasal polyps.
Zhai GT; Li JX; Zhang XH; Liao B; Lu X; Liu Z
Laryngoscope; 2019 Mar; 129(3):E110-E117. PubMed ID: 30570137
[TBL] [Abstract][Full Text] [Related]
37. High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus.
Romagnani P; Annunziato F; Manetti R; Mavilia C; Lasagni L; Manuelli C; Vannelli GB; Vanini V; Maggi E; Pupilli C; Romagnani S
Blood; 1998 May; 91(9):3323-32. PubMed ID: 9558389
[TBL] [Abstract][Full Text] [Related]
38. CD30 is required for activation of a unique subset of interleukin-17A-producing γδ T cells in innate immunity against Mycobacterium bovis Bacillus Calmette-Guerin infection.
Guo Y; Sun X; Shibata K; Yamada H; Muta H; Podack ER; Yoshikai Y
Infect Immun; 2013 Oct; 81(10):3923-34. PubMed ID: 23918785
[TBL] [Abstract][Full Text] [Related]
39. Role for CD30 in HIV expression.
Romagnani S; Annunziato F; Manetti R; Almerigogna F; Biagiotti R; Giudizi MG; Ravina A; Giannò V; Tomasévic L; Maggi E
Immunol Lett; 1996 Jun; 51(1-2):83-8. PubMed ID: 8811349
[TBL] [Abstract][Full Text] [Related]
40. Study of gene expression of CD30 variant (CD30v) and CD30 ligand (CD30L) in acute leukemia.
Essa EA; El Halim SM; Abo-Elenin A; El Bendary A; Abdou SH; Farag W
Egypt J Immunol; 2007; 14(1):11-20. PubMed ID: 18689277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
